ProPublica Reveals Hospitals’ Abortion Debates
In states that banned abortion, doctors are forced to wrestle with tough decisions about high-risk pregnancy care.
Politics and Policy in Medicine
Over the past ten years, patients, advocates and medical professionals have repeatedly sent requests for help to government officials.
Where are the Physician Investors?
Physician entrepreneurs come in many assorted flavors, like technopreneurs, social entrepreneurs, intrapreneurs and consultants.
They Rarely Ask for Pain Pills Now
When I was in my residency training, from 1990-1993, we were in the nascent phase of the ‘pain is a ...
Lawmakers Trying to Remove Licensing Hurdles for Social Workers
Lawmakers are navigating licensing law hurdles so patients can benefit from increased access to social workers.
Biden Administration Makes Right Investments in Mental Health But More Changes Needed
We’ve seen an enormous spike in mental health problems among children—all of which were exacerbated by the COVID pandemic.
Flipping COINs to COPINs
Collaborative Innovation Networks (COINs) have mushroomed since the invention of the Internet and cheap mobile communications.
The Story Behind the Stories in Medicine on Fire
The phrase "medicine is on fire" is often used metaphorically to describe the challenges and pressures that the healthcare industry ...
Health Misinformation is on the Ballot
Election cycles are notable for the spread of misinformation. This year, we will see an unprecedented rise in health misinformation.
To Explain Pain as a Patient
The fact that I’m the one who’s feeling it; your perception may not include what we feel, but can you ...
Healthcare in Space
Anyone familiar with America’s space program will recognize that this nation went through a coma of innovation due to self-inflicted ...
My Struggle to Chronicle Patients
My mission is not only to provide healthcare to my patients but also to shed light on the challenges they ...
Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read more